Reverse Transcription Quantitative PCR (RT-qPCR)

Core Concept

RT-qPCR measures the amount of a specific RNA transcript by first copying it into complementary DNA (cDNA) with a reverse transcriptase, then quantifying that cDNA in real time with PCR that reports fluorescence each cycle. The number of cycles needed for fluorescence to cross a threshold — the Ct (cycle threshold, also written Cq) — is inversely related to how much target was present at the start: more starting transcript gives a lower Ct. Because raw Ct values are affected by RNA input and efficiency, results are normalized against stably expressed reference genes (e.g., GAPDH, ACTB). RT-qPCR is the gold standard for measuring gene expression (mRNA abundance) of defined genes — but it quantifies RNA, not protein, and it cannot by itself prove that a transcript yields functional protein.

Key Components

Reverse transcriptase

• An RNA-dependent DNA polymerase (from retroviruses such as Moloney murine leukemia virus, MMLV) that synthesizes cDNA from an RNA template, typically primed by oligo(dT) (targets poly-A mRNA), random hexamers, or gene-specific primers.

cDNA

• The DNA copy of the RNA of interest; it is the template for the subsequent qPCR. Converting to cDNA lets the stable DNA amplification machinery work on an RNA-derived target.

Fluorescent detection

• SYBR Green — a dye that fluoresces when bound to double-stranded DNA; simple and cheap but binds any dsDNA, so it can also detect primer dimers and nonspecific products.
• TaqMan probe — a sequence-specific oligonucleotide with a fluorophore and quencher; the probe is cleaved during extension, releasing fluorescence only when the correct target is amplified (high specificity, enables multiplexing).

Reference (housekeeping) genes

• Endogenous genes expected to be expressed at constant levels (GAPDH, ACTB, 18S rRNA); used to normalize Ct values and correct for differences in input RNA and reaction efficiency (the ΔΔCt method).

Mechanism

1. Reverse transcription (RT). Total RNA (or mRNA) is incubated with reverse transcriptase and primers to synthesize first-strand cDNA. This is the "RT" step — RNA → cDNA.
2. qPCR amplification. The cDNA is amplified by PCR in the presence of a fluorescent reporter (SYBR Green or TaqMan probe); a detector reads fluorescence every cycle.
3. Threshold and Ct. The instrument plots fluorescence vs. cycle number; the cycle at which fluorescence rises above a set threshold (background) is the Ct. Lower Ct = higher starting amount.
4. Normalization and quantification. Target Ct is compared to reference-gene Ct (ΔCt), then to a calibrator sample (ΔΔCt) for relative quantification, or to a standard curve of known copy numbers for absolute quantification.
5. Quality check. A melt-curve (for SYBR Green) confirms a single product; no-RT and no-template controls are checked for contamination.

Energy and Directionality

Reverse transcriptase synthesizes DNA 5′→3′ from an RNA template, using dNTP hydrolysis for energy; it has no proofreading, so it is more error-prone than DNA polymerases (an acceptable cost for a short diagnostic readout). The subsequent qPCR is standard primer-directed 5′→3′ DNA synthesis powered by dNTP hydrolysis. The "signal" is directional too: fluorescence accumulates only as new double-stranded DNA (or cleaved probe) is produced, so the readout tracks net product formation cycle by cycle.

Experimental Evidence

• What it measures: the relative or absolute abundance of a specific RNA transcript (gene expression), via its cDNA copy.
• Principle: RNA→cDNA by reverse transcription, then real-time fluorescence PCR whose Ct reflects starting target amount.
• Input: purified RNA (quality-checked, DNase-treated), RT enzyme, gene-specific primers, fluorescent reporter, reference-gene primers. Output: a Ct value per target, convertible to fold-change or copy number.
• What it can prove: a transcript is present and how its abundance differs between conditions/tissues/timepoints; a gene is upregulated or downregulated.
• What it cannot prove: protein abundance, protein activity, or post-translational regulation — mRNA and protein levels can diverge; it also cannot detect unknown/new transcripts (that is RNA-Seq's job).
• Controls: no-RT control (omit reverse transcriptase — any signal indicates contaminating genomic DNA, since RNA cannot be amplified by DNA polymerase); no-template control (NTC) (detects reagent contamination and primer dimers); reference genes (normalize input); standard curve (for absolute copy number); melt-curve (confirms specificity).
• Common mistakes: skipping DNase treatment (gDNA falsely inflates signal), poor RNA quality/degradation, primer dimers with SYBR Green, invalid reference genes whose expression actually changes, and reporting raw Ct without normalization.

Common confusions

• "RT-qPCR = regular PCR" — No. RT-qPCR measures RNA by first making cDNA, then quantifying in real time; plain PCR just amplifies DNA and is end-point, not quantitative.
• "A high Ct means more transcript" — Wrong direction: high Ct means less starting transcript (more cycles needed to reach threshold).
• "Housekeeping genes never change" — They are usually stable but must be validated per condition; some change in disease or development.
• "mRNA level = protein level" — Post-transcriptional and post-translational regulation decouple them; RT-qPCR alone cannot claim a functional change.
• "SYBR Green is always specific" — It stains all double-stranded DNA, including primer dimers, so a melt-curve is required to confirm a single product.

Quick review

• Two steps: reverse transcription (RNA→cDNA), then quantitative PCR with fluorescence readout.
• Ct is inversely proportional to starting transcript; normalize to reference genes (ΔΔCt).
• Use no-RT and NTC controls; DNase-treat RNA; validate reference genes.
• Quantifies gene expression (RNA), not protein or function.